Test de connaissances avant formation. ATELIER DE FORMATION DU PERSONNEL DE LABORATOIRE SUR LA PREVENTION DE L’INFECTION A VIRUS EBOLA
Test de connaissances après formation
Issue Brief No. 40 provides healthcare professionals with the most relevant treatment guidelines, prevention measures and training material on MVD
Recommendations to Member States to improve hand hygiene practices to help prevent the transmission of the COVID-19 virus: interim guidance.
WHO recommends member states provide universal access to public hand hygiene stations and making their use obligatory on entering and leaving any public or ...private commercial building and any public transport facility. It is also recommended that healthcare facilities improve access to and practice of hand hygiene.
more
就改进手卫生做法助力预防COVID-19病毒传播给会员国的建议
-1-توصیاتللدول الأعضاء بشأن تحسین ممارسات نظافة الأیدي للمساعدة علىمنع انتقال فیروس كوفید-19
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...e over time. Updated 14 August 2015
more
Morbidity and Mortality Weekly Report (MMWR) Early Release Vol. 64 ; 1 May 2015
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
Objectif du module : Identifier les différents virus de fièvres hémorragiques dont le virus Ebola, ses symptômes, modes de transmission et moyens de prévention
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...d with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
more